Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir to delay HIV treatment initiation in HSV-2/HIV-1 coinfected adults
ISRCTN66756285Phase 4Completed
- Sponsor
- University Health Network
- Start
- Mar 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of valaciclovir in human immunodeficiency virus infection (HIV) and herpes simplex (HSV), sponsored by University Health Network. Primary endpoint: Annual rate of change in CD4 count. Started Mar 2010; status: completed.
02
Drugs
valaciclovir
03
Conditions
human immunodeficiency virus infection (HIV)herpes simplex (HSV)
Beyond the preview
Go deeper on ISRCTN66756285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66756285.